Chicago - Arginine deiminase, an amino acid degrading enzyme, is safe and has anti-tumor activity in phase I and II investigations of metastatic melanoma, according to Theodore Logan, M.D.
Derm In The News: April 28-May 4
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Journal Digest: May 3
ReV Up Your Vitiligo Treatment Strategies
Recognizing Melanoma and Skin Cancer Awareness Month
QUIZ RECAP: Test Your Knowledge of Rosacea Research and Innovations